Time to consider health services dedicated for adults living with cerebral small vessel disease: Report of a ESO scientific seminar
Open Access
- 1 September 2025
- journal article
- research article
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 10 (3) , 675-681
Abstract
Purpose: Cerebral small vessel disease (cSVD) is a highly prevalent disorder leading to physical, cognitive and functional decline. We report key barriers in the management of individuals with cSVD, the potential benefit of cSVD-dedicated health services, and evidence from existing models of care for adults with cSVD. Methods: We examined information from a scientific seminar developed between seven experts in cSVD during the eighth European Stroke Organisation Conference that discussed the optimal health care for adults with cSVD and what health services dedicated to cSVD should include. Findings: Barriers in cSVD care include unrecognised symptoms and modifiable risk factors, heterogeneity of clinical presentations, inefficient inter/intra-clinical services communication/organisation, and uncertainties regarding what assessments/treatments should be routinely done, when and by whom. However, existing health services and research studies suggest models of care in cSVD. Multi-step approaches can be used for identification and aetiological workup in individuals with cSVD, including basic and selected advanced evaluations, for example, monogenic cSVD testing. Although current guidelines for management of cSVD illlustrate limitations, there are recommendations on risk factors and lifestyle considerations, as well as pharmacological and non-pharmacological interventions for people with cSVD. Discussion and conclusion: Existing healthcare models do not provide optimal care for individuals with cSVD. Lack of awareness of heterogeneous clinical presentations and uncertainty in threshold of cSVD ‘burden’ for referral to specialist multidisciplinary services, are key challenges for health services to overcome. Creating cSVD-dedicated services may prevent underdiagnosing and achieve standardised holistic management to improve outcomes in people with cSVD. However, adequate prevention and early management should be offered at all levels of care.Keywords
Funding Information
- Institute of Health Carlos III (Grant for Health Research [RH041992; JR21/00011])
- Swedish Heart and Lung Foundation
- Centre de Neurologie Vasculaire Translationnelle, AP-HP, Hopital Lariboisiere
- The Row Fogo Centre for Research into Aging and the Brain (Ref 486 [AS-CP-18b-001])
- Skåne University Hospital
- The Mexican National Council of Humanities Sciences and Technology (CONAHCYT, 2021-000007-01EXTF-00234)
- The Anne Rowling Clinic Regenerative Neurology
- Swedish Research Council
- Lund University
- UK Dementia Research Institute (4002)
- Fremasons Lodge of Instruction Eos in Lund
- The Stroke Association Garfield Weston Foundation Senior Clinical Lectureship (TSALECT 2015/04)
- Institute of Health Carlos III (Grant for Health Research [RH041992; JR21/00011])
- Swedish Heart and Lung Foundation
- Centre de Neurologie Vasculaire Translationnelle, AP-HP, Hopital Lariboisiere
- The Row Fogo Centre for Research into Aging and the Brain (Ref 486 [AS-CP-18b-001])
- Skåne University Hospital
- The Mexican National Council of Humanities Sciences and Technology (CONAHCYT, 2021-000007-01EXTF-00234)
- The Anne Rowling Clinic Regenerative Neurology
- Swedish Research Council
- Lund University
- UK Dementia Research Institute (4002)
- Fremasons Lodge of Instruction Eos in Lund
- The Stroke Association Garfield Weston Foundation Senior Clinical Lectureship (TSALECT 2015/04)
This publication has 29 references indexed in Scilit:
- Monogenic cerebral small‐vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of NeurologyEuropean Journal of Neurology, 2020
- Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guidelineEuropean Stroke Journal, 2019
- Small vessel disease: mechanisms and clinical implicationsThe Lancet Neurology, 2019
- Canadian Stroke Best Practice Recommendations: Mood, Cognition and Fatigue following Stroke, 6th edition update 2019International Journal of Stroke, 2019
- Clinical practice guideline for cognitive impairment of cerebral small vessel diseaseAging Medicine, 2019
- Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain InjuryJAMA Neurology, 2019
- Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews, 2018
- Nonlinear temporal dynamics of cerebral small vessel diseaseNeurology, 2017
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trialThe Lancet, 2015
- Impact of Age-Related Cerebral White Matter Changes on the Transition to Disability – The LADIS Study: Rationale, Design and MethodologyNeuroepidemiology, 2004